Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways

Molecular Aspects of Medicine

Volumn 50, Issue , 2016, Pages 41-55

  Raynes, Rachel ^a,b   Pomatto, Laura C D ^a,b   Davies, Kelvin J A ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Adaptation; Immunoproteasome; Nrf2; Oxidative Stress; Proteasome; Proteolysis

Indexed keywords

20S CORE PROTEASOME; 26S CORE PROTEASOME; ADENOSINE TRIPHOSPHATE UBIQUITIN; IMMUNOPROTEASOME; PROTEASOME; PROTEINASE; UBIQUITIN; UNCLASSIFIED DRUG; ATP DEPENDENT 26S PROTEASE; PROTEIN; PROTEIN BINDING; PROTEIN SUBUNIT;

ADAPTATION; AGING; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CATALYSIS; CELL SURVIVAL; DEGENERATIVE DISEASE; DNA REPAIR; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME KINETICS; ENZYME REGULATION; HEART FAILURE; HEAT STRESS; HISTONE MODIFICATION; HUMAN; HYDROPHOBICITY; HYPERTENSION; LYSOSOME; MATHEMATICAL ANALYSIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN PROCESSING; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; STOICHIOMETRY; TRANSCRIPTION REGULATION; ANIMAL; CHEMISTRY; DISEASE PREDISPOSITION; METABOLISM; OXIDATION REDUCTION REACTION; PROTEIN SUBUNIT;

ADAPTATION, PHYSIOLOGICAL; AGING; ANIMALS; CATALYSIS; DISEASE SUSCEPTIBILITY; HUMANS; METABOLIC NETWORKS AND PATHWAYS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN SUBUNITS; PROTEINS; PROTEOLYSIS; UBIQUITIN;

EID: 84975159148     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2016.05.001     Document Type: Review

References (166)

1. Adams, J., Kauffman, M., Development of the proteasome inhibitor Velcade™ (Bortezomib). Cancer Invest 22 (2004), 304–311.
2. Ali, A., Bharadwaj, S., O'Carroll, R., Ovsenek, N., HSP90 interacts with and regulates the activity of heat shock factor 1 in Xenopus oocytes. Mol. Cell. Biol 18 (1998), 4949–4960.
3. Ali, A., Wang, Z., Fu, J., Ji, L., Liu, J., Li, L., et al. Differential regulation of the REGgamma-proteasome pathway by p53/TGF-beta signalling and mutant p53 in cancer cells. Nat. Commun, 4, 2013, 2667.
4. Altun, M., Besche, H.C., Overkleeft, H.S., Piccirillo, R., Edelmann, M.J., Kessler, B.M., et al. Muscle wasting in aged, sarcopenic rats is associated with enhanced activity of the ubiquitin proteasome pathway. J. Biol. Chem 285 (2010), 39597–39608.
5. Asher, G., Tsvetkov, P., Kahana, C., Shaul, Y., A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev 19 (2005), 316–321.
6. Baugh, J.M., Viktorova, E.G., Pilipenko, E.V., Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination. J. Mol. Biol 386 (2009), 814–827.
7. Baumeister, W., Walz, J., Zuhl, F., Seemuller, E., The proteasome: paradigm of a self-compartmentalizing protease. Cell 92 (1998), 367–380.
8. Beatty, S., Koh, H.H., Henson, D., Boulton, M., The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol 45 (2000), 115–134.
9. Blasiak, J., Petrovski, G., Vereb, Z., Facsko, A., Kaarniranta, K., Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration. Biomed Res. Int, 2014, 2014, 768026.
10. Blickwedehl, J., Agarwal, M., Seong, C., Pandita, R.K., Melendy, T., Sung, P., et al. Role for proteasome activator PA200 and postglutamyl proteasome activity in genomic stability. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 16165–16170.
11. Bonomini, F., Tengattini, S., Fabiano, A., Bianchi, R., Rezzani, R., Atherosclerosis and oxidative stress. Histol. Histopathol 23 (2008), 381–390.
12. Borissenko, L., Groll, M., 20S proteasome and its inhibitors: crystallographic knowledge for drug development. Chem. Rev 107 (2007), 687–717.
13. Braun, B.C., Glickman, M., Kraft, R., Dahlmann, B., Kloetzel, P.M., Finley, D., et al. The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat. Cell Biol 1 (1999), 221–226.
14. Calderwood, S.K., Murshid, A., Prince, T., The shock of aging: molecular chaperones and the heat shock response in longevity and aging – a mini-review. Gerontology 55 (2009), 550–558.
15. Carrard, G., Bulteau, A.L., Petropoulos, I., Friguet, B., Impairment of proteasome structure and function in aging. Int. J. Biochem. Cell Biol 34 (2002), 1461–1474.
16. Cascio, P., Call, M., Petre, B.M., Walz, T., Goldberg, A.L., Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes. EMBO J. 21 (2002), 2636–2645.
17. Chen, B.B., Mallampalli, R.K., Masking of a nuclear signal motif by monoubiquitination leads to mislocalization and degradation of the regulatory enzyme cytidylyltransferase. Mol. Cell. Biol 29 (2009), 3062–3075.
18. Chen, H., Yoshioka, H., Kim, G.S., Jung, J.E., Okami, N., Sakata, H., et al. Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid. Redox Signal 14 (2011), 1505–1517.
19. Chen, W., Norbury, C.C., Cho, Y., Yewdell, J.W., Bennink, J.R., Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med 193 (2001), 1319–1326.
20. Chondrogianni, N., Stratford, F.L., Trougakos, I.P., Friguet, B., Rivett, A.J., Gonos, E.S., Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J. Biol. Chem 278 (2003), 28026–28037.
21. Christman, M.F., Morgan, R.W., Jacobson, F.S., Ames, B.N., Positive control of a regulon for defenses against oxidative stress and some heat-shock proteins in Salmonella typhimurium. Cell 41 (1985), 753–762.
22. Ciechanover, A., The ubiquitin-proteasome proteolytic pathway. Cell 79 (1994), 13–21.
23. Coux, O., Tanaka, K., Goldberg, A.L., Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem 65 (1996), 801–847.
24. Craiu, A., Gaczynska, M., Akopian, T., Gramm, C.F., Fenteany, G., Goldberg, A.L., et al. Lactacystin and clasto-lactacystin β-lactone modify multiple proteasome β-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J. Biol. Chem 272 (1997), 13437–13445.
25. Cui, Z., Hwang, S.M., Gomes, A.V., Identification of the immunoproteasome as a novel regulator of skeletal muscle differentiation. Mol. Cell. Biol 34 (2014), 96–109.
26. Cutler, R.G., Kelly, J., Storie, K., Pedersen, W.A., Tammara, A., Hatanpaa, K., et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 2070–2075.
27. David, D.C., Layfield, R., Serpell, L., Narain, Y., Goedert, M., Spillantini, M.G., Proteasomal degradation of tau protein. J. Neurochem 83 (2002), 176–185.
28. David, D.C., Ollikainen, N., Trinidad, J.C., Cary, M.P., Burlingame, A.L., Kenyon, C., Widespread protein aggregation as an inherent part of aging in C. elegans. PLoS Biol, 8, 2010, e1000450.
29. Davies, J.M., Lowry, C.V., Davies, K.J., Transient adaptation to oxidative stress in yeast. Arch. Biochem. Biophys 317 (1995), 1–6.
30. Davies, K.J., Protein modification by oxidants and the role of proteolytic enzymes. Biochem. Soc. Trans 21 (1993), 346–353.
31. Davies, K.J., Oxidative stress: the paradox of aerobic life. In: Biochemical Society Symposia, 1995, Portland Press, London, 1–32.
32. Davies, K.J., Degradation of oxidized proteins by the 20S proteasome. Biochimie 83 (2001), 301–310.
33. Deconinck, N., Dan, B., Pathophysiology of Duchenne muscular dystrophy: current hypotheses. Pediatr. Neurol 36 (2007), 1–7.
34. Demontis, F., Perrimon, N., FOXO/4E-BP signaling in Drosophila muscles regulates organism-wide proteostasis during aging. Cell 143 (2010), 813–825.
35. Demple, B., Halbrook, J., Inducible repair of oxidative DNA damage in Escherichia coli. Nature 304 (1983), 466–468.
36. Driscoll, J., Goldberg, A.L., The proteasome (multicatalytic protease) is a component of the 1500-kDa proteolytic complex which degrades ubiquitin-conjugated proteins. J. Biol. Chem 265 (1990), 4789–4792.
37. Dubiel, W., Pratt, G., Ferrell, K., Rechsteiner, M., Purification of an 11 S regulator of the multicatalytic protease. J. Biol. Chem 267 (1992), 22369–22377.
38. Dyson, H.J., Wright, P.E., Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol 6 (2005), 197–208.
39. Etlinger, J.D., Goldberg, A.L., A soluble ATP-dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes. Proc. Natl. Acad. Sci. U.S.A. 74 (1977), 54–58.
40. Eytan, E., Ganoth, D., Armon, T., Hershko, A., ATP-dependent incorporation of 20S protease into the 26S complex that degrades proteins conjugated to ubiquitin. Proc. Natl. Acad. Sci. U.S.A. 86 (1989), 7751–7755.
41. Fabre, B., Lambour, T., Garrigues, L., Ducoux-Petit, M., Amalric, F., Monsarrat, B., et al. Label-free quantitative proteomics reveals the dynamics of proteasome complexes composition and stoichiometry in a wide range of human cell lines. J. Proteome Res 13 (2014), 3027–3037.
42. Fenteany, G., Standaert, R.F., Lane, W.S., Choi, S., Corey, E., Schreiber, S.L., Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268 (1995), 726–731.
43. Finley, D., Sadis, S., Monia, B.P., Boucher, P., Ecker, D.J., Crooke, S.T., et al. Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutant. Mol. Cell. Biol 14 (1994), 5501–5509.
44. Frentzel, S., Pesold-Hurt, B., Seelig, A., Kloetzel, P.M., 20S proteasomes are assembled via distinct precursor complexes. Processing of LMP2 and LMP7 proproteins takes place in 13–16 S preproteasome complexes. J. Mol. Biol 236 (1994), 975–981.
45. Friedberg, E.C., Reversible monoubiquitination of PCNA: a novel slant on regulating translesion DNA synthesis. Mol. Cell 22 (2006), 150–152.
46. Gaczynska, M., Osmulski, P.A., Gao, Y., Post, M.J., Simons, M., Proline-and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activity. Biochemistry 42 (2003), 8663–8670.
47. Gazzerro, E., Assereto, S., Bonetto, A., Sotgia, F., Scarfi, S., Pistorio, A., et al. Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies. Am. J. Pathol 176 (2010), 1863–1877.
48. Giulivi, C., Pacifici, R.E., Davies, K.J., Exposure of hydrophobic moieties promotes the selective degradation of hydrogen peroxide-modified hemoglobin by the multicatalytic proteinase complex, proteasome. Arch. Biochem. Biophys 311 (1994), 329–341.
49. Glickman, M.H., Ciechanover, A., The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev 82 (2002), 373–428.
50. Glickman, M.H., Raveh, D., Proteasome plasticity. FEBS Lett 579 (2005), 3214–3223.
51. Goldberg, A.L., Strnad, N.P., Swamy, K.S., Studies of the ATP dependence of protein degradation in cells and cell extracts. In: Protein Degradation in Health and Disease, Ciba Foundation Symposium, 1980, 227–251.
52. Gonzales McNeal, M., Zareparsi, S., Camicioli, R., Dame, A., Howieson, D., Quinn, J., et al. Predictors of healthy brain aging. J. Gerontol. A. Biol Sci. Med Sci 56 (2001), B294–B301.
53. Griffin, T.A., Nandi, D., Cruz, M., Fehling, H.J., Kaer, L.V., Monaco, J.J., et al. Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J. Exp. Med 187 (1998), 97–104.
54. Groll, M., Huber, R., Substrate access and processing by the 20S proteasome core particle. Int. J. Biochem. Cell Biol 35 (2003), 606–616.
55. Groll, M., Ditzel, L., Lowe, J., Stock, D., Bochtler, M., Bartunik, H.D., et al. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386 (1997), 463–471.
56. Groll, M., Heinemeyer, W., Jäger, S., Ullrich, T., Bochtler, M., Wolf, D.H., et al. The catalytic sites of 20S proteasomes and their role in subunit maturation: a mutational and crystallographic study. Proc. Natl. Acad. Sci. U.S.A. 96 (1999), 10976–10983.
57. Groll, M., Bajorek, M., Köhler, A., Moroder, L., Rubin, D.M., Huber, R., et al. A gated channel into the proteasome core particle. Nat. Struct. Mol. Biol 7 (2000), 1062–1067.
58. Grune, T., Reinheckel, T., Joshi, M., Davies, K.J., Proteolysis in cultured liver epithelial cells during oxidative stress. Role of the multicatalytic proteinase complex, proteasome. J. Biol. Chem 270 (1995), 2344–2351.
59. Grune, T., Reinheckel, T., Davies, K.J., Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome. J. Biol. Chem 271 (1996), 15504–15509.
60. Grune, T., Shringarpure, R., Sitte, N., Davies, K., Age-related changes in protein oxidation and proteolysis in mammalian cells. J. Gerontol. A. Biol Sci. Med Sci 56 (2001), B459–B467.
61. Grune, T., Jung, T., Merker, K., Davies, K.J., Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and ‘aggresomes’ during oxidative stress, aging, and disease. Int. J. Biochem. Cell Biol 36 (2004), 2519–2530.
62. Grune, T., Merker, K., Jung, T., Sitte, N., Davies, K.J., Protein oxidation and degradation during postmitotic senescence. Free Radic. Biol. Med 39 (2005), 1208–1215.
63. Grune, T., Catalgol, B., Licht, A., Ermak, G., Pickering, A.M., Ngo, J.K., et al. HSP70 mediates dissociation and reassociation of the 26S proteasome during adaptation to oxidative stress. Free Radic. Biol. Med 51 (2011), 1355–1364.
64. Hall, M.J., Levant, S., DeFrances, C.J., Hospitalization for congestive heart failure: United States, 2000–2010. NCHS data brief, 2012 1–8.
65. Halliwell, B., Gutteridge, J.M., Free Radicals in Biology and Medicine, vol. 3, 1999, Oxford University Press, Oxford.
66. Hayashi, T., Goto, S., Age-related changes in the 20S and 26S proteasome activities in the liver of male F344 rats. Mech. Ageing Dev 102 (1998), 55–66.
67. Hendil, K.B., Khan, S., Tanaka, K., Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes. Biochem. J. 332:Pt 3 (1998), 749–754.
68. Hermann, J., Gulati, R., Napoli, C., Woodrum, J.E., Lerman, L.O., Rodriguez-Porcel, M., et al. Oxidative stress-related increase in ubiquitination in early coronary atherogenesis. FASEB J. 17 (2003), 1730–1732.
69. Herndon, L.A., Schmeissner, P.J., Dudaronek, J.M., Brown, P.A., Listner, K.M., Sakano, Y., et al. Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature 419 (2002), 808–814.
70. Hershko, A., Ciechanover, A., The ubiquitin system for protein degradation. Annu. Rev. Biochem 61 (1992), 761–807.
71. Hirsch, C., Ploegh, H.L., Intracellular targeting of the proteasome. Trends Cell Biol 10 (2000), 268–272.
72. Holzhütter, H.-G., Kloetzel, P.-M., A kinetic model of vertebrate 20S proteasome accounting for the generation of major proteolytic fragments from oligomeric peptide substrates. Biophys. J. 79 (2000), 1196–1205.
73. Ingles, M., Gambini, J., Carnicero, J.A., Garcia-Garcia, F.J., Rodriguez-Manas, L., Olaso-Gonzalez, G., et al. Oxidative stress is related to frailty, not to age or sex, in a geriatric population: lipid and protein oxidation as biomarkers of frailty. J. Am. Geriatr. Soc 62 (2014), 1324–1328.
74. Jacob, K.D., Noren Hooten, N., Trzeciak, A.R., Evans, M.K., Markers of oxidant stress that are clinically relevant in aging and age-related disease. Mech. Ageing Dev 134 (2013), 139–157.
75. Kallio, P.J., Wilson, W.J., O'Brien, S., Makino, Y., Poellinger, L., Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J. Biol. Chem 274 (1999), 6519–6525.
76. Kastle, M., Reeg, S., Rogowska-Wrzesinska, A., Grune, T., Chaperones, but not oxidized proteins, are ubiquitinated after oxidative stress. Free Radic. Biol. Med 53 (2012), 1468–1477.
77. Katschinski, D.M., Le, L., Schindler, S.G., Thomas, T., Voss, A.K., Wenger, R.H., Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1alpha stabilization. Cell. Physiol. Biochem 14 (2004), 351–360.
78. Keller, J.N., Huang, F.F., Markesbery, W.R., Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neuroscience 98 (2000), 149–156.
79. Kimura, H., Caturegli, P., Takahashi, M., Suzuki, K., New insights into the function of the immunoproteasome in immune and nonimmune cells. J. Immunol. Res, 2015, 2015, 541984.
80. Kisselev, A.F., Akopian, T.N., Woo, K.M., Goldberg, A.L., The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation. J. Biol. Chem 274 (1999), 3363–3371.
81. Kisselev, A.F., Kaganovich, D., Goldberg, A.L., Binding of hydrophobic peptides to several non-catalytic sites promotes peptide hydrolysis by all active sites of 20 S proteasomes. Evidence for peptide-induced channel opening in the alpha-rings. J. Biol. Chem 277 (2002), 22260–22270.
82. Kisselev, A.F., Callard, A., Goldberg, A.L., Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate. J. Biol. Chem 281 (2006), 8582–8590.
83. Kisselev, A.F., van der Linden, W.A., Overkleeft, H.S., Proteasome inhibitors: an expanding army attacking a unique target. Chem. Biol 19 (2012), 99–115.
84. Kloetzel, P.M., Ossendorp, F., Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr. Opin. Immunol 16 (2004), 76–81.
85. Komander, D., The emerging complexity of protein ubiquitination. Biochem. Soc. Trans 37 (2009), 937–953.
86. Kopp, F., Dahlmann, B., Kuehn, L., Reconstitution of hybrid proteasomes from purified PA700-20 S complexes and PA28alphabeta activator: ultrastructure and peptidase activities. J. Mol. Biol 313 (2001), 465–471.
87. Korner, Z., Fontes-Oliveira, C.C., Holmberg, J., Carmignac, V., Durbeej, M., Bortezomib partially improves laminin alpha2 chain-deficient muscular dystrophy. Am. J. Pathol 184 (2014), 1518–1528.
88. Köhler, A., Cascio, P., Leggett, D.S., Woo, K.M., Goldberg, A.L., Finley, D., The axial channel of the proteasome core particle is gated by the Rpt2 ATPase and controls both substrate entry and product release. Mol. Cell 7 (2001), 1143–1152.
89. Kumamoto, T., Fujimoto, S., Ito, T., Horinouchi, H., Ueyama, H., Tsuda, T., Proteasome expression in the skeletal muscles of patients with muscular dystrophy. Acta Neuropathol 100 (2000), 595–602.
90. Lasker, K., Förster, F., Bohn, S., Walzthoeni, T., Villa, E., Unverdorben, P., et al. Molecular architecture of the 26S proteasome holocomplex determined by an integrative approach. Proc. Natl. Acad. Sci. U.S.A. 109 (2012), 1380–1387.
91. Leeuwenburgh, C., Rasmussen, J.E., Hsu, F.F., Mueller, D.M., Pennathur, S., Heinecke, J.W., Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J. Biol. Chem 272 (1997), 3520–3526.
92. Li, H., Horke, S., Forstermann, U., Vascular oxidative stress, nitric oxide and atherosclerosis. Atherosclerosis 237 (2014), 208–219.
93. Li, X., Amazit, L., Long, W., Lonard, D.M., Monaco, J.J., O'Malley, B.W., Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol. Cell 26 (2007), 831–842.
94. Lin, M.T., Beal, M.F., Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443 (2006), 787–795.
95. Lowe, J., Stock, D., Jap, B., Zwickl, P., Baumeister, W., Huber, R., Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science 268 (1995), 533–539.
96. Luciani, F., Keşmir, C., Mishto, M., Or-Guil, M., de Boer, R.J., A Mathematical model of protein degradation by the proteasome. Biophys. J. 88 (2005), 2422–2432.
97. Luker, G.D., Pica, C.M., Song, J., Luker, K.E., Piwnica-Worms, D., Imaging 26S proteasome activity and inhibition in living mice. Nat. Med 9 (2003), 969–973.
98. Lüllmann-Rauch, R., History and morphology of the lysosome. Lysosomes, 2005, Springer, 1–16.
99. Ma, C.P., Slaughter, C.A., DeMartino, G.N., Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). J. Biol. Chem 267 (1992), 10515–10523.
100. Madamanchi, N.R., Vendrov, A., Runge, M.S., Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol 25 (2005), 29–38.
101. Maniatis, T., Goodbourn, S., Fischer, J.A., Regulation of inducible and tissue-specific gene expression. Science 236 (1987), 1237–1245.
102. Medina, R., Wing, S.S., Goldberg, A.L., Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem. J. 307:Pt 3 (1995), 631–637.
103. Meng, L., Mohan, R., Kwok, B.H., Elofsson, M., Sin, N., Crews, C.M., Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc. Natl. Acad. Sci. U.S.A. 96 (1999), 10403–10408.
104. Morimoto, R.I., Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev 22 (2008), 1427–1438.
105. Nerland, D.E., The antioxidant/electrophile response element motif. Drug Metab. Rev 39 (2007), 235–248.
106. Nijman, S.M., Luna-Vargas, M.P., Velds, A., Brummelkamp, T.R., Dirac, A.M., Sixma, T.K., et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 123 (2005), 773–786.
107. Okamura, T., Taniguchi, S., Ohkura, T., Yoshida, A., Shimizu, H., Sakai, M., et al. Abnormally high expression of proteasome activator-gamma in thyroid neoplasm. J. Clin. Endocrinol. Metab 88 (2003), 1374–1383.
108. Ortega, J., Heymann, J.B., Kajava, A.V., Ustrell, V., Rechsteiner, M., Steven, A.C., The axial channel of the 20S proteasome opens upon binding of the PA200 activator. J. Mol. Biol 346 (2005), 1221–1227.
109. Pacifici, R.E., Lin, S.W., Davies, K.J., The measurement of protein degradation in response to oxidative stress. Basic Life Sci 49 (1988), 531–535.
110. Pacifici, R.E., Salo, D.C., Davies, K.J., Macroxyproteinase (M.O.P.): a 670 kDa proteinase complex that degrades oxidatively denatured proteins in red blood cells. Free Radic. Biol. Med 7 (1989), 521–536.
111. Pacifici, R.E., Kono, Y., Davies, K.J., Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multicatalytic proteinase complex, proteasome. J. Biol. Chem 268 (1993), 15405–15411.
112. Pemberton, L.F., Paschal, B.M., Mechanisms of receptor-mediated nuclear import and nuclear export. Traffic 6 (2005), 187–198.
113. Peters, B., Janek, K., Kuckelkorn, U., Holzhütter, H.-G., Assessment of proteasomal cleavage probabilities from kinetic analysis of time-dependent product formation. J. Mol. Biol 318 (2002), 847–862.
114. Pickering, A.M., Davies, K.J., A simple fluorescence labeling method for studies of protein oxidation, protein modification, and proteolysis. Free Radic. Biol. Med 52 (2012), 239–246.
115. Pickering, A.M., Davies, K.J.A., Differential roles of proteasome and immunoproteasome regulators Pa28 alpha beta, Pa28 gamma and Pa200 in the degradation of oxidized proteins. Arch. Biochem. Biophys 523 (2012), 181–190.
116. Pickering, A.M., Linder, R.A., Zhang, H., Forman, H.J., Davies, K.J., Nrf2-dependent induction of proteasome and Pa28alphabeta regulator are required for adaptation to oxidative stress. J. Biol. Chem 287 (2012), 10021–10031.
117. Pickering, A.M., Staab, T.A., Tower, J., Sieburth, D., Davies, K.J., A conserved role for the 20S proteasome and Nrf2 transcription factor in oxidative stress adaptation in mammals, Caenorhabditis elegans and Drosophila melanogaster. J. Exp. Biol 216 (2013), 543–553.
118. Rattan, S.I., Hormesis in aging. Ageing Res. Rev 7 (2008), 63–78.
119. Rechsteiner, M., Hill, C.P., Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol 15 (2005), 27–33.
120. Rechsteiner, M., Realini, C., Ustrell, V., The proteasome activator 11 S REG (PA28) and class I antigen presentation. Biochem. J. 345:Pt 1 (2000), 1–15.
121. Reinheckel, T., Sitte, N., Ullrich, O., Kuckelkorn, U., Davies, K.J., Grune, T., Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem. J. 335:Pt 3 (1998), 637–642.
122. Reinheckel, T., Grune, T., Davies, K.J., The measurement of protein degradation in response to oxidative stress. Methods Mol. Biol 99 (2000), 49–60.
123. Reinheckel, T., Ullrich, O., Sitte, N., Grune, T., Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress. Arch. Biochem. Biophys 377 (2000), 65–68.
124. Reits, E., Neijssen, J., Herberts, C., Benckhuijsen, W., Janssen, L., Drijfhout, J.W., et al. A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity 20 (2004), 495–506.
125. Reuter, S., Gupta, S.C., Chaturvedi, M.M., Aggarwal, B.B., Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic. Biol. Med 49 (2010), 1603–1616.
126. Roessler, M., Rollinger, W., Mantovani-Endl, L., Hagmann, M.L., Palme, S., Berndt, P., et al. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis. Mol. Cell. Proteomics 5 (2006), 2092–2101.
127. Salo, D.C., Pacifici, R.E., Lin, S.W., Giulivi, C., Davies, K.J., Superoxide dismutase undergoes proteolysis and fragmentation following oxidative modification and inactivation. J. Biol. Chem 265 (1990), 11919–11927.
128. Sawada, H., Fukuchi, T., Abe, H., Oxidative stress markers in aqueous humor of patients with senile cataracts. Curr. Eye Res 34 (2009), 36–41.
129. Serviddio, G., Romano, A.D., Greco, A., Rollo, T., Bellanti, F., Altomare, E., et al. Frailty syndrome is associated with altered circulating redox balance and increased markers of oxidative stress. Int. J. Immunopathol. Pharmacol 22 (2009), 819–827.
130. Shang, F., Taylor, A., Oxidative stress and recovery from oxidative stress are associated with altered ubiquitin conjugating and proteolytic activities in bovine lens epithelial cells. Biochem. J. 307 (1995), 297–303.
131. Shang, F., Taylor, A., Ubiquitin-proteasome pathway and cellular responses to oxidative stress. Free Radic. Biol. Med 51 (2011), 5–16.
132. Shang, F., Gong, X., Taylor, A., Activity of ubiquitin-dependent pathway in response to oxidative stress. Ubiquitin-activating enzyme is transiently up-regulated. J. Biol. Chem 272 (1997), 23086–23093.
133. Sharon, M., Witt, S., Felderer, K., Rockel, B., Baumeister, W., Robinson, C.V., 20S proteasomes have the potential to keep substrates in store for continual degradation. J. Biol. Chem 281 (2006), 9569–9575.
134. Shringarpure, R., Davies, K.J., Protein turnover by the proteasome in aging and disease. Free Radic. Biol. Med 32 (2002), 1084–1089.
135. Shringarpure, R., Grune, T., Mehlhase, J., Davies, K.J., Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J. Biol. Chem 278 (2003), 311–318.
136. Sitte, N., Huber, M., Grune, T., Ladhoff, A., Doecke, W.D., Von Zglinicki, T., et al. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J. 14 (2000), 1490–1498.
137. Sitte, N., Merker, K., Von Zglinicki, T., Davies, K.J., Grune, T., Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part II – aging of nondividing cells. FASEB J. 14 (2000), 2503–2510.
138. Sitte, N., Merker, K., Von Zglinicki, T., Grune, T., Davies, K.J., Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part I – effects of proliferative senescence. FASEB J. 14 (2000), 2495–2502.
139. Spector, A., Oxidative stress-induced cataract: mechanism of action. FASEB J. 9 (1995), 1173–1182.
140. Stadtman, E.R., Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu. Rev. Biochem 62 (1993), 797–821.
141. Stenoien, D.L., Cummings, C.J., Adams, H.P., Mancini, M.G., Patel, K., DeMartino, G.N., et al. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum. Mol. Genet 8 (1999), 731–741.
142. Suetta, C., Frandsen, U., Jensen, L., Jensen, M.M., Jespersen, J.G., Hvid, L.G., et al. Aging affects the transcriptional regulation of human skeletal muscle disuse atrophy. PLoS ONE, 7, 2012, e51238.
143. Sykiotis, G.P., Bohmann, D., Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila. Dev. Cell 14 (2008), 76–85.
144. Taguchi, K., Motohashi, H., Yamamoto, M., Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16 (2011), 123–140.
145. Tambyrajah, W.S., Bowler, L.D., Medina-Palazon, C., Sinclair, A.J., Cell cycle-dependent caspase-like activity that cleaves p27(KIP1) is the beta(1) subunit of the 20S proteasome. Arch. Biochem. Biophys 466 (2007), 186–193.
146. Tanahashi, N., Murakami, Y., Minami, Y., Shimbara, N., Hendil, K.B., Tanaka, K., Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. J. Biol. Chem 275 (2000), 14336–14345.
147. Taylor, R.C., Dillin, A., Aging as an event of proteostasis collapse. Cold Spring Harb. Perspect. Biol, 3, 2011, 10.1101/cshperspect.a004440 pii: a004440.
148. Teoh, C.Y., Davies, K.J., Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the ‘PrOxI’ hypothesis. Arch. Biochem. Biophys 423 (2004), 88–96.
149. Texel, S.J., Mattson, M.P., Impaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer's disease. Antioxid. Redox Signal 14 (2011), 1519–1534.
150. Tofaris, G.K., Layfield, R., Spillantini, M.G., alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. FEBS Lett 509 (2001), 22–26.
151. Tsakiri, E.N., Sykiotis, G.P., Papassideri, I.S., Terpos, E., Dimopoulos, M.A., Gorgoulis, V.G., et al. Proteasome dysfunction in Drosophila signals to an Nrf2-dependent regulatory circuit aiming to restore proteostasis and prevent premature aging. Aging Cell 12 (2013), 802–813.
152. Ullrich, O., Reinheckel, T., Sitte, N., Hass, R., Grune, T., Davies, K.J., Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. Proc. Natl. Acad. Sci. U.S.A. 96 (1999), 6223–6228.
153. Ustrell, V., Hoffman, L., Pratt, G., Rechsteiner, M., PA200, a nuclear proteasome activator involved in DNA repair. EMBO J. 21 (2002), 3516–3525.
154. Verhoef, L.G., Lindsten, K., Masucci, M.G., Dantuma, N.P., Aggregate formation inhibits proteasomal degradation of polyglutamine proteins. Hum. Mol. Genet 11 (2002), 2689–2700.
155. Voges, D., Zwickl, P., Baumeister, W., The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem 68 (1999), 1015–1068.
156. Wang, X., Robbins, J., Heart failure and protein quality control. Circ. Res 99 (2006), 1315–1328.
157. Wang, X., Yen, J., Kaiser, P., Huang, L., Regulation of the 26S proteasome complex during oxidative stress. Sci. Signal, 3, 2010, ra88.
158. Wiese, A.G., Pacifici, R.E., Davies, K.J.A., Transient adaptation to oxidative stress in mammalian cells. Arch. Biochem. Biophys 318 (1995), 231–240.
159. Williams, G.R., Incidence and characteristics of total stroke in the United States. BMC Neurol, 1, 2001, 2.
160. Wruck, C.J., Fragoulis, A., Gurzynski, A., Brandenburg, L.O., Kan, Y.W., Chan, K., et al. Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice. Ann. Rheum. Dis 70 (2011), 844–850.
161. Yan, M.H., Wang, X., Zhu, X., Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic. Biol. Med 62 (2013), 90–101.
162. Yang, Y., Fruh, K., Ahn, K., Peterson, P.A., In vivo assembly of the proteasomal complexes, implications for antigen processing. J. Biol. Chem 270 (1995), 27687–27694.
163. Yang, Z., Lin, P.J., Levey, A., Monetary costs of dementia in the United States. N. Engl. J. Med, 369, 2013, 489.
164. Zhang, X.H., Lei, H., Liu, A.J., Zou, Y.X., Shen, F.M., Su, D.F., Increased oxidative stress is responsible for severer cerebral infarction in stroke-prone spontaneously hypertensive rats. CNS Neurosci. Ther 17 (2011), 590–598.
165. Zhang, Z., Zhang, R., Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation. EMBO J. 27 (2008), 852–864.
166. Zhao, W., Zhao, T., Chen, Y., Ahokas, R.A., Sun, Y., Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats. Mol. Cell. Biochem 317 (2008), 43–50.